Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study

[1]  A. Grgic,et al.  Functional Characterization of Patients with Chronic Thromboembolic Disease , 2016, Respiration.

[2]  S. Vanni,et al.  Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model , 2016, European Respiratory Journal.

[3]  Guy Meyer,et al.  Management of Pulmonary Embolism: An Update. , 2016, Journal of the American College of Cardiology.

[4]  G. Hasenfuss,et al.  Comparison of risk assessment strategies for not-high-risk pulmonary embolism , 2016, European Respiratory Journal.

[5]  S. Konstantinides.  Trends in incidence versus case fatality rates of pulmonary embolism: Good news or bad news? , 2015, Thrombosis and Haemostasis.

[6]  F. Piovella,et al.  European Union-28: An annualised cost-of-illness model for venous thromboembolism , 2015, Thrombosis and Haemostasis.

[7]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[8]  Jose Luis Zamorano,et al.  The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .

[9]  F. Klok,et al.  The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. , 2014, Blood reviews.

[10]  M. Revel,et al.  Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism , 2014, Thrombosis and Haemostasis.

[11]  H. Schäfers,et al.  Cardiopulmonary Exercise Testing to Detect Chronic Thromboembolic Pulmonary Hypertension in Patients with Normal Echocardiography , 2014, Respiration.

[12]  D. Fitzmaurice,et al.  [2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. , 2014, Kardiologia polska.

[13]  Jeroen J. Bax,et al.  ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .

[14]  M. Humbert,et al.  Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology ( ESC ) Endorsed by the European Respiratory Society ( ERS ) , 2014 .

[15]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[16]  R. Hetzer,et al.  Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. , 2013, International journal of cardiology.

[17]  M. Humbert,et al.  Pulmonary arterial hypertension , 2013, Orphanet Journal of Rare Diseases.

[18]  J. Yuan,et al.  Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding , 2012, European Respiratory Journal.

[19]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[20]  B. Cosmi,et al.  Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism , 2011, Internal and emergency medicine.

[21]  L. Trinquart,et al.  Perfusion defects after pulmonary embolism: risk factors and clinical significance , 2010, Journal of thrombosis and haemostasis : JTH.

[22]  H. Vliegen,et al.  Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism , 2010, Haematologica.

[23]  H. Vliegen,et al.  Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. , 2010, American journal of respiratory and critical care medicine.

[24]  H. Büller,et al.  Quality of life after pulmonary embolism: validation of the PEmb‐QoL Questionnaire , 2010, Journal of thrombosis and haemostasis : JTH.

[25]  D Bergqvist,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.

[26]  J. Kline,et al.  Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. , 2009, Chest.

[27]  G. Filippatos,et al.  Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .

[28]  W. Auger,et al.  Chronic thromboembolic pulmonary hypertension. , 2009, Seminars in respiratory and critical care medicine.

[29]  E. Oger,et al.  Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.

[30]  J. Kline,et al.  Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients. , 2007, European heart journal.

[31]  L. Kritharides,et al.  Natural history of right ventricular dysfunction after acute pulmonary embolism. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  M. Bottai,et al.  Survival and Restoration of Pulmonary Perfusion in a Long-Term Follow-Up of Patients After Acute Pulmonary Embolism , 2006, Medicine.

[33]  J. SandovalZárate.  Pulmonary arterial hypertension , 2006 .

[34]  M. Huisman,et al.  Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. , 2006, Chest.

[35]  S. Schulman,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[36]  Paolo Prandoni,et al.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.

[37]  E. Minar,et al.  Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. , 2004, Archives of internal medicine.

[38]  A. Alavi,et al.  The clinical course of pulmonary embolism. , 1992, The New England journal of medicine.